Zusammenfassung
Die Debatten um Umfang und Inhalt der Norm einer angemessenen Berücksichtigung der Patienten- und Probandenautonomie wurden im Zusammenhang der Mitteilung molekulargenetischer Zusatzbefunde neu entfacht. Unterbestimmt bleibt dabei häufig die Rolle praktischer Rationalität für autonome Handlungen und Entscheidungen. Der nachfolgende Beitrag skizziert ein adäquates Verständnis praktischer Rationalität und erörtert die Konsequenzen für eine tatsächlich angemessene Berücksichtigung der Patienten- und Probandenautonomie im Rahmen der Mitteilung molekulargenetischer Zusatzbefunde.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Anderson J (2014) Regimes of autonomy. Ethical Theory and Moral Practice 17:355–368
Bartram CR (2012) Aktuelle Aspekte der Humangenetik. In: Bartram CR, Bobbert M, Dölling D et al. (Hrsg) Der (un)durchsichtige Mensch. Wie weit reicht der Blick in die Person? Universitätsverlag Winter, Heidelberg, S 153–171
Beauchamp TL, Childress JF (2013) Principles of biomedical ethics. Oxford University Press, Oxford
Berg JS, Khoury MJ, Evans JP (2011) Deploying whole genome sequencing in clinical practice and public health. Meeting the challenge one bin at a time. Genetics in Medicine 13:499–504
Beskow LM, Friedman JY, Hardy NC et al. (2010) Simplifying informed consent for biorepositories: stakeholder perspectives. Genetics in Medicine 12:567–572
Birnbacher D (2007) Analytische Einführung in die Ethik. Walter de Gruyter, Berlin
Boyd SD, Galli SJ, Schrijver I et al. (2014) A balanced look at the implications of genomic (and other “omics”) testing for disease diagnosis and clinical care. Genes 5:748–766
Brandt RB (1979) A theory of the right and the good. Clarendon Press, Oxford
Bredenoord AL, Onland-Moret NC, van Delden JJM (2011) Feedback of individual genetic results to research participants: in favor of a qualified disclosure policy. Human Mutation 32:861–867
Brownsword R (2004) The cult of consent: fixation and fallacy. King‘s Law Journal 15:223–251
Cheng-Guarjado L (2014) The normative requirement of means-ends rationality and modest bootstrapping. Ethical Theory and Moral Practice 17:487–503
Cho MK (2008) Understanding incidental findings in the context of genetics and genomics. The Journal of Law, Medicine and Ethics 36:208–212
Christman J (2011) The politics of persons. Individual autonomy and sociohistorical selves. Cambridge University Press, Cambridge
Clayton EW (2008) Incidental findings in genetics research using archived DNA. The Journal of Law, Medicine and Ethics 36:286–291
Craigie J (2011) Competence, practical rationality and what a patient values. Bioethics 25:326–333
Dal-Ré R, Katsanis N, Katsanis S et al. (2014) Managing incidental genomic findings in clinical trials: fulfillment of the principle of justice. PLoS Medicine 11:e1001584
Deutsche Gesellschaft für Humangenetik (2013) Stellungnahme zu genetischen Zusatzbefunden in Diagnostik und Forschung. http://www.gfhev.de/de/leitlinien/LL_und_Stellungnahmen/2013_05_28_Stellungnahme_zu_genetischen_Zufallsbefunden.pdf. Zugegriffen: 20.11.2014
Donchin A (2000) Autonomy and interdependence. Quandaries in genetic decision making. In: Mackenzie C, Stoljar N (Hrsg) Relational autonomy. Feminist perspectives on autonomy, agency, and the social self. Oxford University Press, Oxford, S 236–258
Dworkin G (1988) The theory and practice of autonomy. Cambridge University Press, Cambridge
Feinberg J (1986) Harm to self: the moral limits of the criminal law. Oxford University Press, Oxford
Forgó N, Petersen I, Kollek R et al. (2010) Ethical and legal requirements for transnational genetic research. C.H. Beck, München
Friedrich O, Heinrichs J-H (2014) Autonomie als Rechtfertigungsgrund psychiatrischer Therapien. Ethik in der Medizin 26:317–330
Green RC, Berg JS, Grody WW et al. (2013) ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine 15:565–574
Greulich H (2010) The genomics of lung adenocarcinoma: opportunities for targeted therapies. Genes & Cancer 1:1200–1210
Kollek R (2009): Informed consent. Comment on Article 6. In: Ten Have HAMJ, Jean MS (Hrsg) Universal Declaration on Bioethics and Human Rights. Background, principles and application. UNESCO Publishing. Ethics series, Paris, S 123–138
Langanke M, Erdmann P (2011) Die MRT als wissenschaftliche Studienuntersuchung und das Problem der Mitteilung von Zufallsbefunden. Probandenethische Herausforderungen. In: Theissen H, Langanke M (Hrsg) Tragfähige Rede von Gott. Festgabe zum 50. Geburtstag von Heinrich Assel am 9. Februar 2011. Kovac, Hamburg, S 197–240
Lewis A, James P (2012) An incidental finding of a large genomic deletion of BRCA1 on a molecular karyotype for a 5 year old child. Hereditary Cancer in Clinical Practice 10(Supplement 2):A73
Lord E (2014a) The coherent and the rational. Analytic Philosophy 55:151–175
Lord E (2014b) The real symmetry problem(s) for wide-scope accounts of rationality. Philosophical Studies 170:443–464
Lucassen A, Houlston RS (2014) The challenges of genome analysis in the health care setting. Genes 5:576–585
Manson NC, O'Neill O (2008) Rethinking informed consent in bioethics. Cambridge University Press, Cambridge
Mardis ER, Ding L, Dooling DJ et al. (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. New England Journal of Medicine 361:1058–1066
McGuire AL, Beskow LM (2010) Informed consent in genomics and genetic research. Annual Review of Genomics and Human Genetics 22:361–381
Meacham MC, Starks H, Burke W et al. (2010) Researcher perspectives on disclosure of incidental findings in genetic research. Journal of Empirical Research on Human Research Ethics: An International Journal 5:31–41
Mestan KK, Ilkhanoff L, Mouli S et al (2011) Genomic sequencing in clinical trials. Journal of Translational Medicine 9:222
O’Neill O (2003) Autonomy: the Emperor’s new clothes. Aristotelian Society Supplementary Volume 77:1–21
O’Roak BJ, Deriziotis P, Lee C et al. (2011) Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature Genetics 43:585–589
Owen GS, Freyenhagen F, Richardson G et al. (2009) Mental capacity and decisional autonomy: an interdisciplinary challenge. Inquiry 52:79–107
Parfit D (1984) Reasons and persons. Oxford University Press, Oxford
Parker LS (2008) The future of incidental findings: Should they be viewed as benefits? The Journal of Law, Medicine and Ethics 36:341–351
Projektgruppe EURAT (2013) Eckpunkte für eine Heidelberger Praxis der Ganzgenomsequenzierung. Marsilius-Kolleg der Universität Heidelberg, Heidelberg
Richardson HS (2001) Autonomy's many normative presuppositions. American Philosophical Quarterly 38:287–303
Rotimi CN, Marshall PA (2010) Tailoring the process of informed consent in genetic and genomic research. Genome Medicine 2:20
Rudnik-Schöneborn S, Langanke M, Erdmann P et al. (2014) Ethische und rechtliche Aspekte im Umgang mit genetischen Zufallsbefunden – Herausforderungen und Lösungsansätze. Ethik in der Medizin 26:105–119
Schroeder M (2008) Having reasons. Philosophical Studies 139:57–71
Schroeder M (2009) Means-end coherence, stringency, and subjective reasons. Philosophical Studies 143:223–248
Spohn W (1993) Wie kann die Theorie der Rationalität normativ und empirisch zugleich sein? In: Eckensberger LH, Gähde U (Hrsg) Ethische Norm und empirische Hypothese. Suhrkamp, Frankfurt a. Main, S 151–196
Van Ness B (2008) Genomic research and incidental findings. The Journal of Law, Medicine and Ethics 36:292–297
Vilarino-Guell C, Wider C, Ross OA et al. (2011) VPS35 mutations in parkinson disease. The American Journal of Human Genetics 89:162–167
Völzke H, Alte D, Schmidt CO et al. (2011) Cohort Profile: The study of health in Pomerania. International Journal of Epidemiology 40:294–307
Vogelstein E (2014) Competence and ability. Bioethics 28:235–244
Walker T (2013) Respecting autonomy without disclosing information. Bioethics 27:388–394
Williams B (1979) Internal and external reasons. In: Harrison R (Hrsg) Rational action. Cambridge University Press, Cambridge, S 101–113
Winkler EC, Ose D,·Glimm H et al. (2013) Personalisierte Medizin und Informed Consent: Klinische und ethische Erwägungen im Rahmen der Entwicklung einer Best Practice Leitlinie für die biobankbasierte Ganzgenomforschung in der Onkologie. Ethik in der Medizin 25:195–203
Wolf SM, Lawrenz FP, Nelson CA et al (2008) Managing incidental findings in human subjects research: analysis and recommendations. The Journal of Law, Medicine and Ethics 36:219–248
Wolf SM, Annas GJ, Elias S (2013) Patient autonomy and incidental findings in clinical genomics. Science 340:1049–1050
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schleidgen, S. (2015). Autonomie , Rationalität und angemessene Aufklärung im Kontext molekulargenetischer Zusatzbefunde. In: Langanke, M., Erdmann, P., Robienski, J., Rudnik-Schöneborn, S. (eds) Zufallsbefunde bei molekulargenetischen Untersuchungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46217-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-46217-1_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46216-4
Online ISBN: 978-3-662-46217-1
eBook Packages: Medicine (German Language)